Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

HROW Harrow Health Inc

Price (delayed)

$29.51

Market cap

$1.08B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.61

Enterprise value

$1.25B

Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton ...

Highlights
HROW's gross profit has soared by 64% YoY and by 6% QoQ
HROW's revenue has surged by 53% year-on-year and by 7% since the previous quarter
The EPS rose by 34% year-on-year but it has declined by 24% since the previous quarter
Harrow Health's net income has increased by 31% YoY but it has decreased by 24% from the previous quarter
Harrow Health's quick ratio has plunged by 69% YoY and by 57% from the previous quarter
Harrow Health's debt has increased by 20% YoY

Key stats

What are the main financial stats of HROW
Market
Shares outstanding
36.7M
Market cap
$1.08B
Enterprise value
$1.25B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
18.64
Price to sales (P/S)
4.97
EV/EBIT
522.77
EV/EBITDA
66.83
EV/Sales
5.86
Earnings
Revenue
$212.86M
Gross profit
$158.64M
Operating income
$4.52M
Net income
-$21.7M
EBIT
$2.38M
EBITDA
$18.65M
Free cash flow
$421,000
Per share
EPS
-$0.61
EPS diluted
-$0.61
Free cash flow per share
$0.01
Book value per share
$1.58
Revenue per share
$5.94
TBVPS
$5.06
Balance sheet
Total assets
$364.16M
Total liabilities
$308.07M
Debt
$230.01M
Equity
$56.45M
Working capital
-$17.45M
Liquidity
Debt to equity
4.07
Current ratio
0.91
Quick ratio
0.77
Net debt/EBITDA
8.76
Margins
EBITDA margin
8.8%
Gross margin
74.5%
Net margin
-10.2%
Operating margin
2.1%
Efficiency
Return on assets
-6.1%
Return on equity
-35.8%
Return on invested capital
1.1%
Return on capital employed
1.3%
Return on sales
1.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HROW stock price

How has the Harrow Health stock price performed over time
Intraday
0.58%
1 week
13.85%
1 month
14.22%
1 year
69.5%
YTD
-12.04%
QTD
10.94%

Financial performance

How have Harrow Health's revenue and profit performed over time
Revenue
$212.86M
Gross profit
$158.64M
Operating income
$4.52M
Net income
-$21.7M
Gross margin
74.5%
Net margin
-10.2%
Harrow Health's operating income has soared by 159% YoY but it has decreased by 49% from the previous quarter
HROW's operating margin has surged by 138% year-on-year but it has dropped by 52% since the previous quarter
HROW's gross profit has soared by 64% YoY and by 6% QoQ
Harrow Health's net margin has soared by 55% YoY but it has decreased by 16% from the previous quarter

Price vs fundamentals

How does HROW's price correlate with its fundamentals

Growth

What is Harrow Health's growth rate over time

Valuation

What is Harrow Health stock price valuation
P/E
N/A
P/B
18.64
P/S
4.97
EV/EBIT
522.77
EV/EBITDA
66.83
EV/Sales
5.86
The EPS rose by 34% year-on-year but it has declined by 24% since the previous quarter
The stock's price to book (P/B) is 33% less than its 5-year quarterly average of 27.9
Harrow Health's equity has decreased by 19% from the previous quarter and by 7% YoY
HROW's revenue has surged by 53% year-on-year and by 7% since the previous quarter
HROW's P/S is 20% below its last 4 quarters average of 6.2 but 18% above its 5-year quarterly average of 4.2

Efficiency

How efficient is Harrow Health business performance
The ROIC has soared by 128% YoY but it has plunged by 54% from the previous quarter
The return on sales has surged by 118% year-on-year but it has dropped by 59% since the previous quarter
The return on assets is up by 46% year-on-year but it has declined by 17% since the previous quarter
Harrow Health's return on equity has increased by 34% YoY but it has decreased by 27% QoQ

Dividends

What is HROW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HROW.

Financial health

How did Harrow Health financials performed over time
The total assets is 18% greater than the total liabilities
Harrow Health's current ratio has shrunk by 70% YoY and by 56% QoQ
Harrow Health's quick ratio has plunged by 69% YoY and by 57% from the previous quarter
The debt to equity has grown by 29% YoY and by 24% from the previous quarter
Harrow Health's debt has increased by 20% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.